Surinabant

DB13070

small molecule investigational

Deskripsi

Surinabant has been investigated for the treatment of Smoking Cessation.

Struktur Molekul 2D

Berat 522.27
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

839 Data
Cocaine Cocaine may increase the tachycardic activities of Surinabant.
Trospium The risk or severity of Tachycardia and drowsiness can be increased when Trospium is combined with Surinabant.
Oxyphenonium The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Surinabant.
Benzatropine The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Surinabant.
Disopyramide The risk or severity of Tachycardia and drowsiness can be increased when Disopyramide is combined with Surinabant.
Ipratropium The risk or severity of Tachycardia and drowsiness can be increased when Ipratropium is combined with Surinabant.
Metixene The risk or severity of Tachycardia and drowsiness can be increased when Metixene is combined with Surinabant.
Terfenadine The risk or severity of Tachycardia and drowsiness can be increased when Terfenadine is combined with Surinabant.
Buclizine The risk or severity of Tachycardia and drowsiness can be increased when Buclizine is combined with Surinabant.
Trihexyphenidyl The risk or severity of Tachycardia and drowsiness can be increased when Trihexyphenidyl is combined with Surinabant.
Oxyphencyclimine The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with Surinabant.
Procyclidine The risk or severity of Tachycardia and drowsiness can be increased when Procyclidine is combined with Surinabant.
Profenamine The risk or severity of Tachycardia and drowsiness can be increased when Profenamine is combined with Surinabant.
Hyoscyamine The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Surinabant.
Methscopolamine bromide The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine bromide is combined with Surinabant.
Darifenacin The risk or severity of Tachycardia and drowsiness can be increased when Darifenacin is combined with Surinabant.
Tridihexethyl The risk or severity of Tachycardia and drowsiness can be increased when Tridihexethyl is combined with Surinabant.
Anisotropine methylbromide The risk or severity of Tachycardia and drowsiness can be increased when Anisotropine methylbromide is combined with Surinabant.
Atropine The risk or severity of Tachycardia and drowsiness can be increased when Atropine is combined with Surinabant.
Nicardipine The risk or severity of Tachycardia and drowsiness can be increased when Nicardipine is combined with Surinabant.
Pirenzepine The risk or severity of Tachycardia and drowsiness can be increased when Pirenzepine is combined with Surinabant.
Homatropine methylbromide The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with Surinabant.
Benzquinamide The risk or severity of Tachycardia and drowsiness can be increased when Benzquinamide is combined with Surinabant.
Propantheline The risk or severity of Tachycardia and drowsiness can be increased when Propantheline is combined with Surinabant.
Dicyclomine The risk or severity of Tachycardia and drowsiness can be increased when Dicyclomine is combined with Surinabant.
Biperiden The risk or severity of Tachycardia and drowsiness can be increased when Biperiden is combined with Surinabant.
Quinidine The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with Surinabant.
Methantheline The risk or severity of Tachycardia and drowsiness can be increased when Methantheline is combined with Surinabant.
Cycrimine The risk or severity of Tachycardia and drowsiness can be increased when Cycrimine is combined with Surinabant.
Glycopyrronium The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Surinabant.
Tolterodine The risk or severity of Tachycardia and drowsiness can be increased when Tolterodine is combined with Surinabant.
Oxybutynin The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with Surinabant.
Flavoxate The risk or severity of Tachycardia and drowsiness can be increased when Flavoxate is combined with Surinabant.
Diphenidol The risk or severity of Tachycardia and drowsiness can be increased when Diphenidol is combined with Surinabant.
Tiotropium The risk or severity of Tachycardia and drowsiness can be increased when Tiotropium is combined with Surinabant.
Solifenacin The risk or severity of Tachycardia and drowsiness can be increased when Solifenacin is combined with Surinabant.
Isopropamide The risk or severity of Tachycardia and drowsiness can be increased when Isopropamide is combined with Surinabant.
Mepenzolate The risk or severity of Tachycardia and drowsiness can be increased when Mepenzolate is combined with Surinabant.
Fesoterodine The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Surinabant.
Hexocyclium The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Surinabant.
Dimetindene The risk or severity of Tachycardia and drowsiness can be increased when Dimetindene is combined with Surinabant.
Aclidinium The risk or severity of Tachycardia and drowsiness can be increased when Aclidinium is combined with Surinabant.
Dexetimide The risk or severity of Tachycardia and drowsiness can be increased when Dexetimide is combined with Surinabant.
Umeclidinium The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Surinabant.
Trimebutine The risk or severity of Tachycardia and drowsiness can be increased when Trimebutine is combined with Surinabant.
Imidafenacin The risk or severity of Tachycardia and drowsiness can be increased when Imidafenacin is combined with Surinabant.
Butylscopolamine The risk or severity of Tachycardia and drowsiness can be increased when Butylscopolamine is combined with Surinabant.
Thonzylamine The risk or severity of Tachycardia and drowsiness can be increased when Thonzylamine is combined with Surinabant.
Methscopolamine The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine is combined with Surinabant.
Revefenacin The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with Surinabant.
Oxitropium The risk or severity of Tachycardia and drowsiness can be increased when Oxitropium is combined with Surinabant.
Propiverine The risk or severity of Tachycardia and drowsiness can be increased when Propiverine is combined with Surinabant.
Batefenterol The risk or severity of Tachycardia and drowsiness can be increased when Batefenterol is combined with Surinabant.
Mebeverine The risk or severity of Tachycardia and drowsiness can be increased when Mebeverine is combined with Surinabant.
Tropatepine The risk or severity of Tachycardia and drowsiness can be increased when Tropatepine is combined with Surinabant.
Prifinium The risk or severity of Tachycardia and drowsiness can be increased when Prifinium is combined with Surinabant.
Piperidolate The risk or severity of Tachycardia and drowsiness can be increased when Piperidolate is combined with Surinabant.
Benzilone The risk or severity of Tachycardia and drowsiness can be increased when Benzilone is combined with Surinabant.
Difemerine The risk or severity of Tachycardia and drowsiness can be increased when Difemerine is combined with Surinabant.
Phenglutarimide The risk or severity of Tachycardia and drowsiness can be increased when Phenglutarimide is combined with Surinabant.
Mazaticol The risk or severity of Tachycardia and drowsiness can be increased when Mazaticol is combined with Surinabant.
Etybenzatropine The risk or severity of Tachycardia and drowsiness can be increased when Etybenzatropine is combined with Surinabant.
Otilonium The risk or severity of Tachycardia and drowsiness can be increased when Otilonium is combined with Surinabant.
Poldine The risk or severity of Tachycardia and drowsiness can be increased when Poldine is combined with Surinabant.
Bevonium The risk or severity of Tachycardia and drowsiness can be increased when Bevonium is combined with Surinabant.
Rociverine The risk or severity of Tachycardia and drowsiness can be increased when Rociverine is combined with Surinabant.
Bornaprine The risk or severity of Tachycardia and drowsiness can be increased when Bornaprine is combined with Surinabant.
Etanautine The risk or severity of Tachycardia and drowsiness can be increased when Etanautine is combined with Surinabant.
Tiemonium iodide The risk or severity of Tachycardia and drowsiness can be increased when Tiemonium iodide is combined with Surinabant.
Dihexyverine The risk or severity of Tachycardia and drowsiness can be increased when Dihexyverine is combined with Surinabant.
Penthienate The risk or severity of Tachycardia and drowsiness can be increased when Penthienate is combined with Surinabant.
Diphemanil The risk or severity of Tachycardia and drowsiness can be increased when Diphemanil is combined with Surinabant.
Camylofin The risk or severity of Tachycardia and drowsiness can be increased when Camylofin is combined with Surinabant.
Fenpiverinium The risk or severity of Tachycardia and drowsiness can be increased when Fenpiverinium is combined with Surinabant.
Emetonium iodide The risk or severity of Tachycardia and drowsiness can be increased when Emetonium iodide is combined with Surinabant.
Pipenzolate The risk or severity of Tachycardia and drowsiness can be increased when Pipenzolate is combined with Surinabant.
Timepidium The risk or severity of Tachycardia and drowsiness can be increased when Timepidium is combined with Surinabant.
Chlorphenoxamine The risk or severity of Tachycardia and drowsiness can be increased when Chlorphenoxamine is combined with Surinabant.
Phentermine The risk or severity of Tachycardia can be increased when Surinabant is combined with Phentermine.
Midodrine The risk or severity of Tachycardia can be increased when Surinabant is combined with Midodrine.
Norepinephrine The risk or severity of Tachycardia can be increased when Surinabant is combined with Norepinephrine.
Phenylephrine The risk or severity of Tachycardia can be increased when Surinabant is combined with Phenylephrine.
Phenylpropanolamine The risk or severity of Tachycardia can be increased when Surinabant is combined with Phenylpropanolamine.
Labetalol The risk or severity of Tachycardia can be increased when Surinabant is combined with Labetalol.
Metaraminol The risk or severity of Tachycardia can be increased when Surinabant is combined with Metaraminol.
Epinephrine The risk or severity of Tachycardia can be increased when Surinabant is combined with Epinephrine.
Methoxamine The risk or severity of Tachycardia can be increased when Surinabant is combined with Methoxamine.
Orciprenaline The risk or severity of Tachycardia can be increased when Surinabant is combined with Orciprenaline.
Phenmetrazine The risk or severity of Tachycardia can be increased when Surinabant is combined with Phenmetrazine.
Dobutamine The risk or severity of Tachycardia can be increased when Surinabant is combined with Dobutamine.
Pseudoephedrine The risk or severity of Tachycardia can be increased when Surinabant is combined with Pseudoephedrine.
Ritodrine The risk or severity of Tachycardia can be increased when Surinabant is combined with Ritodrine.
Terbutaline The risk or severity of Tachycardia can be increased when Surinabant is combined with Terbutaline.
Oxymetazoline The risk or severity of Tachycardia can be increased when Surinabant is combined with Oxymetazoline.
Dopamine The risk or severity of Tachycardia can be increased when Surinabant is combined with Dopamine.
Isoprenaline The risk or severity of Tachycardia can be increased when Surinabant is combined with Isoprenaline.
Acebutolol The risk or severity of Tachycardia can be increased when Surinabant is combined with Acebutolol.
Lisdexamfetamine The risk or severity of Tachycardia can be increased when Surinabant is combined with Lisdexamfetamine.
Fenoterol The risk or severity of Tachycardia can be increased when Surinabant is combined with Fenoterol.
Ephedrine The risk or severity of Tachycardia can be increased when Surinabant is combined with Ephedrine.

Target Protein

Cannabinoid receptor 1 CNR1

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul